ArticlePediatric rheumatology online journal2021

Ruxolitinib treatment permits lower cumulative glucocorticoid dosing in children with secondary hemophagocytic lymphohistiocytosis.

Ying Chi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.